EP Patent

EP2062585A1 — The antibiotics composition comprising aminoglycoside antibiotics

Assigned to Tianjin Hemay Biotechnology Co Ltd · Expires 2009-05-27 · 17y expired

What this patent protects

The antibiotics composition comprising at least one of aminoglycoside antibiotics and at least one of ionic chelating agents used for inhibiting particulate formation, or at least one of buffers, or at least one of ionic chelating agents and buffers simultaneously. The compositio…

USPTO Abstract

The antibiotics composition comprising at least one of aminoglycoside antibiotics and at least one of ionic chelating agents used for inhibiting particulate formation, or at least one of buffers, or at least one of ionic chelating agents and buffers simultaneously. The composition can be formulated into solution, or combined with at least one of beta-lactam antibiotics, or combined with at least one of beta-lactam antibiotics and at least one of beta-lactamase inhibitors into solutions for controlling microbial infection in a container.

Drugs covered by this patent

Patent Metadata

Patent number
EP2062585A1
Jurisdiction
EP
Classification
—
Expires
2009-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Hemay Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.